Concepedia

Ramona Lopez

RL

Statistics

Publications

8

Citations

389

H-Index

8

Active since

2013

Affiliations

The University of Texas Southwestern Medical Center(Current)

Baylor University

National Institutes of Health

Frederick National Laboratory for Cancer Research

National Cancer Institute

Ramona Lopez is an author at The University of Texas Southwestern Medical Center specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2013–2018

8

Publications

8

Chemiluminescent probes for imaging H<sub>2</sub>S in living animals

Jian Cao, Ramona Lopez, J. M. Thacker et al. · Chemical Science · 2015 · 160 citations · Full text

Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent

Mallinath B. Hadimani, Matthew T. MacDonough, Anjan Ghatak et al. · Journal of Natural Products · 2013 · 59 citations · Full text

, , +20

Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents

Laxman Devkota, Chen-Ming Lin, Tracy E. Strecker et al. · Bioorganic & Medicinal Chemistry · 2016 · 46 citations · Full text

, , +9

The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts

Tracy E. Strecker, Samuel O. Odutola, Ramona Lopez et al. · Cancer Letters · 2015 · 33 citations · Full text

, , +14

Evaluation of tumor ischemia in response to an indole-based vascular disrupting agent using BLI and (19)F MRI.

Heling Zhou, Rami R. Hallac, Ramona Lopez et al. · PubMed · 2015 · 27 citations

, , +26

1–5 of 8